Graham Capital Management’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$330K	Buy	11,765 +6,420	+120%	+$211K	0.01%	783
2025 Q4	$200K	Sell	5,345 -5,032	-48%	-$165K	﹤0.01%	1044
2025 Q3	$286K	Sell	10,377 -2,471	-19%	-$85.1K	﹤0.01%	885
2025 Q2	$406K	Sell	12,848 -3,467	-21%	-$112K	0.01%	900
2025 Q1	$541K	Buy	16,315 +1,625	+11%	+$58.3K	0.01%	770
2024 Q4	$505K	Buy	+14,690	New	+$505K	0.01%	733
2024 Q3	–	Sell	-10,523	Closed	-$317K	–	1195
2024 Q2	$317K	Sell	10,523 -15,241	-59%	-$458K	0.01%	714
2024 Q1	$865K	Buy	+25,764	New	+$827K	0.02%	464
2023 Q3	–	Sell	-14,585	Closed	-$513K	–	1139
2023 Q2	$513K	Sell	14,585 -103,548	-88%	-$3.57M	0.01%	550
2023 Q1	$3.86M	Buy	118,133 +85,405	+261%	+$3.89M	0.12%	118
2022 Q4	$1.8M	Buy	32,728 +15,529	+90%	+$854K	0.05%	319
2022 Q3	$761K	Buy	+17,199	New	+$839K	0.03%	598
2022 Q2	–	Sell	-6,166	Closed	-$299K	–	1119
2022 Q1	$299K	Buy	+6,166	New	+$251K	0.01%	733